Custom Search

FDA Information

The FDA approved topotecan on May 29th 1996 for the treatment of metastatic ovarian cancer, and then later in December 1998, for the treatment of small cell lung cancer.

Following this, in June 2006, topotecan in combination with cisplatin was approved for advanced cervical cancer that cannot be treated with radiation therapy or surgery. 

Please visit the official site of the FDA for further information.


Why is this medication prescribed?

Other uses for this medicine

Dosage and using this medicine

What special precautions should I follow?

What should I do if I forget a dose?

What side effects can this medication cause?

What storage conditions are needed for this medicine?

In case of an emergency/overdose


Use of this site is subject to the following terms of use